ROKIT Healthcare Inc. (KOSDAQ:376900)
27,600
0.00 (0.00%)
At close: Sep 9, 2026
ROKIT Healthcare Revenue
ROKIT Healthcare had revenue of 8.22B KRW in the quarter ending June 30, 2026, with 36.64% growth. This brings the company's revenue in the last twelve months to 32.81B, up 106.19% year-over-year. In the year 2025, ROKIT Healthcare had annual revenue of 26.25B with 100.19% growth.
Revenue (ttm)
32.81B
Revenue Growth
+106.19%
P/S Ratio
14.61
Revenue / Employee
n/a
Employees
n/a
Market Cap
479.25B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.25B | 13.14B | 100.19% |
| Dec 31, 2024 | 13.11B | 693.67M | 5.59% |
| Dec 31, 2023 | 12.42B | 3.27B | 35.70% |
| Dec 31, 2022 | 9.15B | 2.41B | 35.76% |
| Dec 31, 2021 | 6.74B | 2.75B | 68.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| HansBiomed | 124.81B |
| S.Biomedics | 16.49B |
| curacle co.,ltd. | 8.24B |
| Qurient | 7.07B |
| IntoCell | 3.19B |
| Kangstem Biotech | 3.03B |
| Inventage Lab | 2.47B |
| AprilBio | 725.35M |